XML 70 R55.htm IDEA: XBRL DOCUMENT v3.19.2
Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jul. 01, 2018
Jun. 30, 2019
Jul. 01, 2018
Segment Reporting Information [Line Items]        
Percentage Change In Sales By Geographic Area (1.30%)   (0.60%)  
Sales to customers $ 20,562 $ 20,830 $ 40,583 $ 40,839
Percentage Change in Operating Income Loss 41.60%   9.70%  
Earnings before provision for taxes on income $ 7,041 4,973 $ 11,463 10,454
In-process research and development     890 0
Restructuring charges 57 57 93 99
CONSUMER        
Segment Reporting Information [Line Items]        
Sales to customers 3,544 3,504 6,862 6,902
Litigation expense 200   200  
PHARMACEUTICAL        
Segment Reporting Information [Line Items]        
Sales to customers 10,529 10,354 20,773 20,198
In-process research and development     900  
Litigation expense     400  
Research and Development Expense     300  
Medical Devices        
Segment Reporting Information [Line Items]        
Sales to customers 6,489 6,972 12,948 13,739
Restructuring charges 100 100 100 200
Litigation expense 200 700 300 700
Operating Segments        
Segment Reporting Information [Line Items]        
Total Segment Operating Income $ 7,272 5,276 $ 11,841 11,069
Percentage Change in Operating Income Loss 37.80%   7.00%  
Operating Segments | CONSUMER        
Segment Reporting Information [Line Items]        
Total Segment Operating Income $ 406 829 $ 1,147 1,377
Percentage Change in Operating Income Loss (51.00%)   (16.70%)  
Amortization $ 100 100 $ 200 100
Gain (Loss) on Disposition of Assets   300   300
Operating Segments | PHARMACEUTICAL        
Segment Reporting Information [Line Items]        
Total Segment Operating Income $ 3,677 3,651 $ 6,008 7,317
Percentage Change in Operating Income Loss 0.70%   (17.90%)  
Amortization $ 800 800 $ 1,600 1,500
Gain (Loss) on Disposition of Assets   100   100
Unrealized Gain (Loss) on Securities 200   300  
Operating Segments | Medical Devices        
Segment Reporting Information [Line Items]        
Total Segment Operating Income 3,189 796 $ 4,686 2,375
Percentage Change in Operating Income Loss     97.30%  
Amortization 200 300 $ 500 500
Corporate, Non-Segment        
Segment Reporting Information [Line Items]        
Total Segment Operating Income 231 303 378 615
Ci:z Holdings Co. Ltd. | CONSUMER        
Segment Reporting Information [Line Items]        
Gain on sale of equity investments     300  
Actelion | PHARMACEUTICAL        
Segment Reporting Information [Line Items]        
Acquisition related costs $ 100 100 $ 100 200
United States        
Segment Reporting Information [Line Items]        
Percentage Change In Sales By Geographic Area (2.20%)   (0.30%)  
Sales to customers $ 10,403 10,640 $ 20,532 20,591
United States | CONSUMER        
Segment Reporting Information [Line Items]        
Sales to customers 1,537 1,476 2,975 2,912
United States | PHARMACEUTICAL        
Segment Reporting Information [Line Items]        
Sales to customers 5,783 5,899 11,365 11,253
United States | Medical Devices        
Segment Reporting Information [Line Items]        
Sales to customers $ 3,083 3,265 $ 6,192 6,426
Europe        
Segment Reporting Information [Line Items]        
Percentage Change In Sales By Geographic Area (1.60%)   (2.80%)  
Sales to customers $ 4,733 4,810 $ 9,342 9,607
Western Hemisphere, excluding U.S.        
Segment Reporting Information [Line Items]        
Percentage Change In Sales By Geographic Area (5.50%)   (4.80%)  
Sales to customers $ 1,455 1,540 $ 2,958 3,107
Asia-Pacific, Africa        
Segment Reporting Information [Line Items]        
Percentage Change In Sales By Geographic Area 3.40%   2.90%  
Sales to customers $ 3,971 $ 3,840 $ 7,751 $ 7,534
ADVANCED | Operating Segments | Medical Devices        
Segment Reporting Information [Line Items]        
Gain (Loss) on Disposition of Business $ 2,000   $ 2,000